OBJECTIVES: Sleep apnea (SA) is common in patients with end-stage renal disease (ESRD) and such patients are likely to suffer additional sleep disruption associated with restless legs syndrome (RLS) and periodic leg movements (PLM). Our objective was to evaluate sleep quality in ESRD patients who are newly diagnosed with SAand determine the additional contribution of PLM to sleep disruption. METHODS: Two groups of patients with SA (apnea-hypopnea index (AHI) > 15) were compared, one with ESRD (n = 12) and the other with normal renal function (n = 18), using a sleep history questionnaire, sleep diary, Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, polysomnography (1 night) and actigraphy (6 nights). RESULTS: The prevalence of RLS was higher in ESRD patients (60% vs 6%, p < 0.001). ESRD patients had shorter total sleep time (TST) (264 +/- 78 vs 330 +/- 46 min, p = 0.01), lower sleep efficiency (68 +/- 20 % vs 81 +/- 11 %, p = 0.03), and more stage 1 NREM sleep (23 +/- 18 vs 8 +/- 5 % TST, p = 0.002). ESRD patients had a higher frequency of PLM (31 +/- 37 hr-1 vs 8.0 +/- 16 hr-1, p = 0.02) and PLM-related arousals (15 +/- 18 hr-1 vs 1 +/- 2 hr-1, p = 0.003). Actigraphy demonstrated a higher movement and fragmentation index in ESRD patients (23 +/- 10 % sleep time vs 17 +/- 6 % sleep time, p = 0.04). CONCLUSIONS: The co-existence of PLM is an additional source of sleep disruption in patients with ESRD and SA. Treatment of PLM, in addition to treatment of sleep apnea, may be required to improve sleep quality in this patient population.
OBJECTIVES:Sleep apnea (SA) is common in patients with end-stage renal disease (ESRD) and such patients are likely to suffer additional sleep disruption associated with restless legs syndrome (RLS) and periodic leg movements (PLM). Our objective was to evaluate sleep quality in ESRDpatients who are newly diagnosed with SAand determine the additional contribution of PLM to sleep disruption. METHODS: Two groups of patients with SA (apnea-hypopnea index (AHI) > 15) were compared, one with ESRD (n = 12) and the other with normal renal function (n = 18), using a sleep history questionnaire, sleep diary, Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, polysomnography (1 night) and actigraphy (6 nights). RESULTS: The prevalence of RLS was higher in ESRDpatients (60% vs 6%, p < 0.001). ESRDpatients had shorter total sleep time (TST) (264 +/- 78 vs 330 +/- 46 min, p = 0.01), lower sleep efficiency (68 +/- 20 % vs 81 +/- 11 %, p = 0.03), and more stage 1 NREM sleep (23 +/- 18 vs 8 +/- 5 % TST, p = 0.002). ESRDpatients had a higher frequency of PLM (31 +/- 37 hr-1 vs 8.0 +/- 16 hr-1, p = 0.02) and PLM-related arousals (15 +/- 18 hr-1 vs 1 +/- 2 hr-1, p = 0.003). Actigraphy demonstrated a higher movement and fragmentation index in ESRDpatients (23 +/- 10 % sleep time vs 17 +/- 6 % sleep time, p = 0.04). CONCLUSIONS: The co-existence of PLM is an additional source of sleep disruption in patients with ESRD and SA. Treatment of PLM, in addition to treatment of sleep apnea, may be required to improve sleep quality in this patient population.
Authors: Emma K Larkin; Carol L Rosen; H Lester Kirchner; Amy Storfer-Isser; Judith L Emancipator; Nathan L Johnson; Anna Marie V Zambito; Russell P Tracy; Nancy S Jenny; Susan Redline Journal: Circulation Date: 2005-04-19 Impact factor: 29.690
Authors: H Klar Yaggi; John Concato; Walter N Kernan; Judith H Lichtman; Lawrence M Brass; Vahid Mohsenin Journal: N Engl J Med Date: 2005-11-10 Impact factor: 91.245
Authors: Michael Walsh; Braden J Manns; Scott Klarenbach; Robert Quinn; Marcello Tonelli; Bruce F Culleton Journal: BMC Nephrol Date: 2006-02-22 Impact factor: 2.388
Authors: Laura M Campbell; Bin Tang; C Wei-Ming Watson; Michael Higgins; Mariana Cherner; Brook L Henry; Raeanne C Moore Journal: Cannabis Date: 2020-07-03
Authors: Lianne M Kurina; Kristen L Knutson; Louise C Hawkley; John T Cacioppo; Diane S Lauderdale; Carole Ober Journal: Sleep Date: 2011-11-01 Impact factor: 5.849
Authors: David J Allsop; Delwyn J Bartlett; Jennifer Johnston; David Helliwell; Adam Winstock; Iain S McGregor; Nicholas Lintzeris Journal: J Clin Sleep Med Date: 2015-10-15 Impact factor: 4.062
Authors: J Matthew Thomas; Philip A Kern; Heather M Bush; Kristen J McQuerry; W Scott Black; Jody L Clasey; Julie S Pendergast Journal: JCI Insight Date: 2020-02-13
Authors: Jennifer L Guida; Alfonso J Alfini; Lisa Gallicchio; Adam P Spira; Neil E Caporaso; Paige A Green Journal: Sleep Date: 2021-07-09 Impact factor: 5.849
Authors: Laura M Campbell; Maulika Kohli; Ellen E Lee; Christopher N Kaufmann; Michael Higgins; Jeremy D Delgadillo; Robert K Heaton; Mariana Cherner; Ronald J Ellis; David J Moore; Raeanne C Moore Journal: Clin Neuropsychol Date: 2020-09-30 Impact factor: 4.373